Marc Combalia

Marc Combalia

Auto-generated profile, based on publicly available information

Marc Combalia

Hospital Clínic of Barcelona, Barcelona, Spain

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 May 2019 in IEEE Communications Magazine
Verified
Journal Article
Open access
IDIlker Demirkol
Ilker Demirkol
DMDaniel Camps Mur
Daniel Camps Mur
JPJosep Paradells
Josep Paradells
MCMarc Combalia
Marc Combalia
Wasiu PopoolaWasiu Popoola
Wasiu Popoola
HHHarald Haas
Harald Haas
Novel solutions are required to connect billions of devices to the network as envisioned by the IoT. In this article we propose to use LiFi, which is based on off-the-shelf LEDs, as an enabler for the IoT in indoor environments. We present LiFi4IoT, a system which, in addition to communication, provides three main services that the radio frequency (RF) IoT networks struggle to offer: precise device positioning; the possibility of delivering power, since energy can be harvested from light; and inherent security due to the propagation properties of visible light. We analyze the application space of IoT in indoor scenarios, and propose a LiFi4IoT access point (AP) that communicates simultaneously with IoT devices featuring different types of detectors, such as CMOS camera sensors, PDs, and solar cells. Based on the capabilities of these technologies, we define three types of energy self-sufficient IoT “motes” and analyze their feasibility. Finally, we identify the main research directions to enable the LiFi4IoT vision and provide preliminary results for several of these.

27 September 2023 in Journal of the European Academy of Dermatology and Venereology
Verified
Journal Article
Open access
TSTobias Sangers
Tobias Sangers
HKHARALD KITTLER
HARALD KITTLER
ABAndreas Blum
Andreas Blum
RBRalph P. Braun
Ralph P. Braun
CBCatarina Barata
Catarina Barata
TFThe Eadv Ai Task Force
The Eadv Ai Task Force
Background: As the use of smartphones continues to surge globally, mobile applications (apps) have become a powerful tool for healthcare engagement. Prominent among these are dermatology apps powered by Artificial Intelligence (AI), which provide immediate diagnostic guidance and educational resources for skin diseases, including skin cancer.Objective: This article, authored by the EADV AI Task Force, seeks to offer insights and recommendations for the present and future deployment of AI‐assisted smartphone applications (apps) and web‐based services for skin diseases with emphasis on skin cancer detection.Methods: An initial position statement was drafted on a comprehensive literature review, which was subsequently refined through two rounds of digital discussions and meticulous feedback by the EADV AI Task Force, ensuring its accuracy, clarity and relevance.Results: Eight key considerations were identified, including risks associated with inaccuracy and improper user education, a decline in professional skills, the influence of non‐medical commercial interests, data security, direct and indirect costs, regulatory approval and the necessity of multidisciplinary implementation. Following these considerations, three main recommendations were formulated: (1) to ensure user trust, app developers should prioritize transparency in data quality, accuracy, intended use, privacy and costs; (2) Apps and web‐based services should ensure a uniform user experience for diverse groups of patients; (3) European authorities should adopt a rigorous and consistent regulatory framework for dermatology apps to ensure their safety and accuracy for users.Conclusions: The utilisation of AI‐assisted smartphone apps and web‐based services in diagnosing and treating skin diseases has the potential to greatly benefit patients in their dermatology journeys. By prioritising innovation, fostering collaboration and implementing effective regulations, we can ensure the successful integration of these apps into clinical practice.


1 November 2022 in British Journal of Dermatology
Verified
Journal Article
Open access
NCNeus Calbet-Llopart
Neus Calbet-Llopart
MCMarc Combalia
Marc Combalia
AKAnil Kiroglu
Anil Kiroglu
MPMiriam Potrony
Miriam Potrony
GTGemma Tell-Martí
Gemma Tell-Martí
JBJoan Anton Puig Butillé
Joan Anton Puig Butillé
Summary: Background: Hypomorphic MC1R variants are the most prevalent genetic determinants of melanoma risk in the white population. However, the genetic background of patients with wildtype (WT) MC1R melanoma is poorly studied. Objectives: To analyse the role of candidate common genetic variants on the melanoma risk and naevus count in Spanish patients with WT MC1R melanoma. Methods: We examined 753 individuals with WT MC1R from Spain (497 patients and 256 controls). We used OpenArray reverse-transcriptase polymerase chain reaction to genotype a panel of 221 common genetic variants involved in melanoma, naevogenesis, hormonal pathways and proinflammatory pathways. Genetic models were tested using multivariate logistic regression models. Nonparametric multifactor dimensionality reduction (MDR) was used to detect gene–gene interactions within each biological subgroup of variants. Results: We found that variant rs12913832 in the HERC2 gene, which is associated with blue eye colour, increased melanoma risk in individuals with WT MC1R [odds ratio (OR) 1·97, 95% confidence interval (CI) 1·48–2·63; adjusted P < 0·001; corrected P < 0·001]. We also observed a trend between the rs3798577 variant in the oestrogen receptor alpha gene (ESR1) and a lower naevus count, which was restricted to female patients with WT MC1R (OR 0·51, 95% CI 0·33–0·79; adjusted P = 0·002; corrected P = 0·11). This sex-dependent association was statistically significant in a larger cohort of patients with melanoma regardless of their MC1R status (n = 1497; OR 0·71, 95% CI 0·57–0·88; adjusted P = 0·002), reinforcing the hypothesis of an association between hormonal pathways and susceptibility to melanocytic proliferation. Last, the MDR analysis revealed four genetic combinations associated with melanoma risk or naevus count in patients with WT MC1R. Conclusions: Our data suggest that epistatic interaction among common variants related to melanocyte biology or proinflammatory pathways might influence melanocytic proliferation in individuals with WT MC1R. What is already known about this topic? Genetic variants in the MC1R gene are the most prevalent melanoma genetic risk factor in the white population. Still, 20–40% of cases of melanoma occur in individuals with wildtype MC1R.Multiple genetic variants have a pleiotropic effect in melanoma and naevogenesis. Additional variants in unexplored pathways might also have a role in melanocytic proliferation in these patients.Epidemiological evidence suggests an association of melanocytic proliferation with hormonal pathways and proinflammatory pathways. What does this study add? Variant rs12913832 in the HERC2 gene, which is associated with blue eye colour, increases the melanoma risk in individuals with wildtype MC1R.Variant rs3798577 in the oestrogen receptor gene is associated with naevus count regardless of the MC1R status in female patients with melanoma.We report epistatic interactions among common genetic variants with a role in modulating the risk of melanoma or the number of naevi in individuals with wildtype MC1R. What is the translational message? We report a potential role of hormonal signalling pathways in melanocytic proliferation, providing a basis for better understanding of sex-based differences observed at the epidemiological level.We show that gene–gene interactions among common genetic variants might be responsible for an increased risk for melanoma development in individuals with a low-risk phenotype, such as darkly pigmented hair and skin.

7 September 2023 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
KLKonstantinos Liopyris
Konstantinos Liopyris
Cristian Navarrete-DechentCristian Navarrete-Dechent
Cristian Navarrete-Dechent
MMMichael A. Marchetti
Michael A. Marchetti
VRVeronica Rotemberg
Veronica Rotemberg
ZAZoe Apalla
Zoe Apalla
AMAshfaq A. Marghoob
Ashfaq A. Marghoob

3 December 2018
Verified
Conference Paper
Open access
VVVerónica Vilaplana
Verónica Vilaplana
MCMarc Combalia
Marc Combalia
We propose a patch sampling strategy based on a sequential Monte-Carlo method for high resolution image classification in the context of Multiple Instance Learning. When compared with grid sampling and uniform sampling techniques, it achieves higher generalization performance. We validate the strategy on two artificial datasets and two histological datasets for breast cancer and sun exposure classification.